We facilitate breakthrough research and share cutting-edge knowledge
about side effects resulting from cancer medication
IMPAQTT is an independent foundation that contributes substantially to lifesaving new cancer therapies. The focus is on the new treatment options, the so-called targeted therapies. The IMPAQTT Foundation, founded in 2012 as TARGET-RCI, operates as a partner in the management of cancer treatment-associated side effects.
The IMPAQTT Foundation is CancerMed’s Side Effects Research & Valorisation Foundation. CancerMed Side Effects Institute operates as a partner in the management of cancer treatment-associated side effects. While CancerMed Side Effects Institute focuses on the education and certification of health care professionals, the IMPAQTT Foundation focuses on research and valorisation.
Science-based side effects knowledge made available for day-to-day care
The primary objective of the IMPAQTT Foundation is to conduct leading research on targeted anticancer therapy-associated side effects assessing frequency and severity, and their prevention and management in order to bring cancer treatment to a higher level.
The secondary objective of the IMPAQTT Foundation is to develop and disseminate widely best evidence for prevention and management of targeted anticancer therapy-associated side effects as well as to expand their availability and use in daily practice in order to encourage full-dose-on-time treatment.
At IMPAQTT Foundation we demonstrate that with simple, low-cost methods, millions of people suffering from side effects of the cancer treatments can be redeemed. Cancer therapy, for example, costs per patient between €6,000-€15,000 each month. Simple methods exist to treat the side effects of targeted cancer therapies, such as vinegar baths.
We want to spread the word and conduct more research.
We are training as many doctors, nurses, and patients as possible around the world.
We have built up a global network of oncologists, nurses, and scientists - all experts in their respective field – from Australia, Belgium, Brazil, China, Cyprus, Denmark, France, Germany, Greece, Italy, Oman, Singapore, South Africa, The Netherlands, Turkey, USA, and many more.